Overall rank by patents
#9,541
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Kindeva Drug Delivery L.P.
USPTO PatentsView assignee record — 33 granted patents across 13 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
33
Total patents granted
13
CPC technology areas
17.6
Avg claims per patent
—
5-year filing velocity
Portfolio overview
Kindeva Drug Delivery L.P. has been granted 33 US utility patents between 2020 and 2025, placing Kindeva Drug Delivery L.P. at rank #9,541 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Kindeva Drug Delivery L.P. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 44.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 33 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Kindeva Drug Delivery L.P.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Kindeva Drug Delivery L.P. against peers pursuing similar technology classes.
How does Kindeva compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Kindeva Drug Deli… ◀ 33
Kindeva Drug Delivery L.P.
33 patents
What this shows Kindeva holds 33 patents — placing it at rank #9,541 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2020–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 4 | 12.1% |
| 2021 | 8 | 24.2% |
| 2022 | 9 | 27.3% |
| 2023 | 6 | 18.2% |
| 2024 | 2 | 6.1% |
| 2025 | 4 | 12.1% |
Which technologies does Kindeva Drug Delivery L.P. patent most?
Top 13 of 13 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Frequently Asked Questions
How many patents does Kindeva Drug Delivery L.P. hold?
Kindeva Drug Delivery L.P. holds 33 US granted patents filed between 2020 and 2025, spanning 13 technology areas.
What is Kindeva Drug Delivery L.P.'s Innovation Score?
Kindeva Drug Delivery L.P. has an Innovation Score of 44.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Kindeva Drug Delivery L.P. focus on?
Kindeva Drug Delivery L.P.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 31 patents. The company has filed patents in 13 CPC subclasses total.
Is Kindeva Drug Delivery L.P.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Kindeva Drug Delivery L.P..
What does claim depth mean for Kindeva Drug Delivery L.P.'s patents?
Kindeva Drug Delivery L.P.'s patents average 17.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Kindeva Drug Delivery L.P. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61M technology
Kindeva Drug Delivery L.P.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Kindeva Drug Delivery L.P. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
